Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lingxi Liu, Qingping Zhang & Huali Peng. (2023) Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer. Journal of Chemotherapy 35:1, pages 39-52.
Read now
Read now
Min Du & Jianbo Yin. (2022) Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy. Drug Design, Development and Therapy 16, pages 4139-4149.
Read now
Read now
Zhaoqiang Dong, Yuzhen Wang, Jing Guo, Chuan Tian, Wengu Pan, Hongwei Wang & Jieke Yan. (2022) Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity. Drug Design, Development and Therapy 16, pages 2683-2693.
Read now
Read now
Sabya Sachi Das, Srushti Tambe, Priya Ranjan Prasad Verma, Purnima Amin, Neeru Singh, Sandeep Kumar Singh & Piyush Kumar Gupta. (2022) Molecular Insights and Therapeutic Implications of Nanoengineered Dietary Polyphenols for Targeting Lung Carcinoma: Part I. Nanomedicine 17:23, pages 1779-1798.
Read now
Read now
Ziyang Xue, Dan Mei & Lingling Zhang. (2022) Advances in single-cell nanoencapsulation and applications in diseases. Journal of Microencapsulation 39:5, pages 481-494.
Read now
Read now
Quhui Wu, Huiping Ou, Yan Shang, Xi Zhang, Junyong Wu & Fuyuan Fan. (2021) Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer. Drug Design, Development and Therapy 15, pages 2695-2709.
Read now
Read now
Articles from other publishers (16)
Anis Askarizadeh & Amirhossein Sahebkar. 2024. Curcumin-Based Nanomedicines as Cancer Therapeutics. Curcumin-Based Nanomedicines as Cancer Therapeutics
257
290
.
Sarah Almofty, Vijaya Ravinayagam, Norah Alghamdi, Wejdan Alghamdi, Zainab Albazroun, Layan Almulla, Sultan Akhtar, Ali Awad Almofleh, Gazali Tanimu, H. Dafalla & B. Rabindran Jermy. (2023) Effect of CeO2/spherical silica and halloysite nanotubes engineered for targeted drug delivery system to treat breast cancer cells. OpenNano 13, pages 100169.
Crossref
Crossref
Shin-Tian Chien, Ian T. Suydam & Kim A. Woodrow. (2023) Prodrug approaches for the development of a long-acting drug delivery systems. Advanced Drug Delivery Reviews 198, pages 114860.
Crossref
Crossref
Gehad Subaiea, Syed Mohd Danish Rizvi, Hemant Kumar Singh Yadav, Turki Al Hagbani, Marwa Helmy Abdallah, El-Sayed Khafagy, Hosahalli Veerabhadrappa Gangadharappa, Talib Hussain & Amr Selim Abu Lila. (2023) Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells. Pharmaceuticals 16:2, pages 230.
Crossref
Crossref
Tongyu LiWeiwei ShiJie YaoJingyun HuQiong SunJing MengJian WanHaihan SongHangxiang Wang. (2022) Combinatorial nanococktails via self-assembling lipid prodrugs for synergistically overcoming drug resistance and effective cancer therapy. Biomaterials Research 26:1.
Crossref
Crossref
Ranmali Ranasinghe, Michael L. Mathai & Anthony Zulli. (2022) Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon 8:9, pages e10608.
Crossref
Crossref
Quan Gao, Jiao Feng, Wencheng Liu, Chengyong Wen, Yihan Wu, Qian Liao, Liang Zou, Xinbing Sui, Tian Xie, Jinming Zhang & Yichen Hu. (2022) Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Advanced Drug Delivery Reviews 188, pages 114445.
Crossref
Crossref
S. R. Pavan & Ashwini Prabhu. (2022) Advanced cisplatin nanoformulations as targeted drug delivery platforms for lung carcinoma treatment: a review. Journal of Materials Science 57:34, pages 16192-16227.
Crossref
Crossref
Thayse V. de Oliveira, Renan Stein, Diego F. de Andrade & Ruy C. R. Beck. (2022) Preclinical studies of the antitumor effect of curcumin‐loaded polymeric nanocapsules: A systematic review and meta‐analysis. Phytotherapy Research 36:8, pages 3202-3214.
Crossref
Crossref
Mohamed Haider, Amr Elsherbeny, Valeria Pittalà, Valeria Consoli, Maha Ali Alghamdi, Zahid Hussain, Ghalia Khoder & Khaled Greish. (2022) Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer. International Journal of Molecular Sciences 23:3, pages 1853.
Crossref
Crossref
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, Farid Hashemi, Amirhossein Zabolian, Fardin Hashemi, Pourya Raee, Shahin Aghamiri, Milad Ashrafizadeh, Amir Reza Aref, Michael R. Hamblin, Kiavash Hushmandi, Ali Zarrabi & Gautam Sethi. (2021) Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytotherapy Research 36:1, pages 189-213.
Crossref
Crossref
Yaseen Hussain, Lubna Islam, Haroon Khan, Rosanna Filosa, Michael Aschner & Saba Javed. (2021) Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects. Phytotherapy Research 35:12, pages 6514-6529.
Crossref
Crossref
Man Zhou, Yan Luo, Weijia Zeng, Xiaoqing Yang, Tingting Chen, Lulu Zhang, Xiaoyan He, Xiuguang Yi, Yongxiu Li & Xiaoqing Yi. (2021) A Co-delivery System Based on a Dimeric Prodrug and Star-Shaped Polymeric Prodrug Micelles for Drug Delivery. Frontiers in Chemistry 9.
Crossref
Crossref
Qiu-Ping Feng, Yu-Ting Zhu, Yi-Zhen Yuan, Wen-Jie Li, Hao-Han Yu, Meng-Yuan Hu, Su-Yun Xiang & Shu-Qin Yu. (2021) Oral administration co-delivery nanoparticles of docetaxel and bevacizumab for improving intestinal absorption and enhancing anticancer activity. Materials Science and Engineering: C 124, pages 112039.
Crossref
Crossref
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, Hossein Saleki, Seyed Mohammad Reza Torabi, Adnan Ranjbar, SeyedHesam SeyedSaleh, Seyed Omid Sharifzadeh, Haroon Khan, Milad Ashrafizadeh, Ali Zarrabi & Kwang-seok Ahn. (2021) Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules 26:8, pages 2382.
Crossref
Crossref
Chen Cheng, Binglin Sui, Mingming Wang, Xiangxiang Hu, Shanshan Shi & Peisheng Xu. (2020) Carrier‐Free Nanoassembly of Curcumin–Erlotinib Conjugate for Cancer Targeted Therapy. Advanced Healthcare Materials 9:19.
Crossref
Crossref